Premium
Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations
Author(s) -
PavyLe Traon Anne,
Cotterill Nikki,
Amarenco Gerard,
Duerr Susanne,
Kaufmann Horacio,
Lahrmann Heinz,
Tison François,
Wenning Gregor K.,
Goetz Christopher G.,
Poewe Werner,
Sampaio Cristina,
Schrag Anette,
Rascol Olivier,
MartinezMartin Pablo,
Stebbins Glenn T.
Publication year - 2018
Publication title -
movement disorders clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.754
H-Index - 18
ISSN - 2330-1619
DOI - 10.1002/mdc3.12636
Subject(s) - medicine , rating scale , lower urinary tract symptoms , physical therapy , quality of life (healthcare) , urinary incontinence , parkinson's disease , nocturia , international prostate symptom score , disease , overactive bladder , urinary system , psychology , urology , alternative medicine , pathology , prostate , developmental psychology , nursing , cancer
Background The prevalence of lower urinary tract symptoms (LUTS) is high in Parkinson's disease (PD). These problems negatively affect quality of life and include both storage and voiding problems. The International Parkinson and Movement Disorder Society established a task force to review clinical rating scales/questionnaires for the assessment of urinary symptoms in PD. Methods According to prespecified criteria, these scales/questionnaires were classified as “Recommended” or “Recommended with caveats” when clinimetric properties were satisfactory for Recommended status but had not been assessed specifically in PD, “Suggested” or “Listed.” These assessments were applied to rate scales as screening tools for the diagnosis of LUTS and for the rating of symptom severity. Results Among scales that included LUTS but focused on overall autonomic or non‐motor symptoms in PD, no scale reached the clinimetric rigor to be designated as Recommended or Recommended with caveats, but some were Suggested for either diagnostic screening tools or severity measures. Among primary urological scales, most are well validated in urological setting, but none was validated specifically in PD. DAN‐PSS (Danish PSS), ICIQ (International Consultation for Incontinence Questionnaire)‐MLUTS (Male Lower Urinary Tract Symptoms), OABq, OABq‐SF (ICIQ‐OABqol), OAB‐V8 (as screening tool), and OABSS (OAB Symptom Score) met criteria for Recommended with caveats. Conclusion The Task Force does not recommend the development of a new scale. However, all above‐mentioned questionnaires need to be studied further and specifically validated in PD.